Prime Medicine, Inc. Common Stock
XNAS:PRME
4.38
$8.91 - 3,000.00
$3.91 - 100.00
$4.34
$4.66
$4.66
$4.68
6.94
1.11
2254563
3572446.4
93816259.99
Chart
TendieTensor AI Analysis
Company
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Fundamentals
214
-3.000000
4.936150
100
BBG011RT3R55
BBG011RT3R64
134.57M
178.27M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own PRME. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.